Shield Therapeutics plc announced that Hans-Peter Rudolf is joining the company’s Senior Executive Team as Chief Financial Officer with immediate effect. Hans-Peter is a Swiss national with extensive international experience, particularly in the US. He began his career in 1991 in public practice with Deloitte in Cleveland, Ohio, before moving back to Switzerland in 1996 to join Ernst & Young (EY) where he became a partner in 2001. In 2003 he moved back to Cleveland with EY, as an audit partner in the Cleveland office, and then between 2006 to 2010 as an audit partner with Crowe Horwath (now Crowe). In 2011 Hans-Peter left public practice to become Head of Group Accounting at COFRA Group. In 2017, he was appointed as Chief Financial Officer at Vicarius Pharma.